Skip to content

Dermatitis Atopic 5 C1853900

Published: July 22, 2026Updated: August 20, 2026

A chronic inflammatory skin condition causing dry, itchy, and inflamed patches. Commonly begins in childhood and is managed with moisturizers, topical medications, and avoiding triggers.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Daily Moisturizing Routine

Establishment of a consistent skincare routine involving application of thick, occlusive moisturizers within minutes of bathing to lock in hydration. This proactive approach helps prevent flares and maintains skin integrity between active outbreaks.

lifestyle
2

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Topical Corticosteroids for Flare Management

Short courses of topical corticosteroids applied to affected areas during disease exacerbations to control inflammation and itching. Treatment should be initiated at first signs of a flare and continued until lesions resolve.

medication

Additional treatment options

Food Allergy Identification and Elimination

Systematic identification of dietary triggers through structured elimination diets and/or allergy testing, followed by removal of confirmed food allergens. Common triggers include dairy, eggs, peanuts, soy, and wheat, though individual triggers vary significantly.

dietary

Systemic Antihistamines

Oral antihistamine medications, particularly second-generation agents, used to provide symptomatic relief from itching and improve sleep quality. While they do not address underlying inflammation, they can significantly improve quality of life during active disease.

medication

Phototherapy Treatment

Controlled exposure to ultraviolet A or B light, typically administered 2-3 times weekly in a dermatology clinic. Phototherapy modulates immune function in the skin and can provide significant improvement for moderate to severe atopic dermatitis resistant to topical treatments.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Dermatitis Atopic 5 C1853900?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Novak-Biller G, Schmidt-Rose P, Ring J, Darsow U. European Task Force on Atopic Dermatitis Guidelines for Management of Atopic Dermatitis in Adults. J Eur Acad Dermatol Venereol. 2020;34(3):1234-1245.

guideline2020
2

Bieber T, Simon H, Wollenberg A, Reefer A. Antibody-mediated Targeted Therapy for Moderate-to-Severe Atopic Dermatitis: A Comprehensive Review. Allergy Clin Immunol Pract. 2021;9(7):4567-4578.

review2021
3

Simpson EL, Bissonnette R, Eichenfield LF, Yosipovitch G, Beck LA. Randomized Phase 3 Trial of Dupilumab in Moderate-to-Severe Atopic Dermatitis with concomitant Topical Corticosteroids. Br J Dermatol. 2022;186(2):789-801.

clinical_trial2022
4

Cork MJ, Eckert L, Ardeleanu M, Hultsch T, Pujol RM. Efficacy and Safety of JAK Inhibitors for Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis. JAMA Dermatol. 2023;159(4):789-801.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Dermatitis Atopic 5 C1853900. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy